VivArt-X has successfully closed a pre-seed investment round of 660.000 euros, thanks to the support of Brabant Startup Fund, the Brabantse Ontwikkelings Maatschappij (BOM), TU/e Participation Holding (the Gate), and a group of informal investors. Obtaining this funding will allow them to advance their lead program to pre-clinical development, a significant step toward enhancing regenerative […]

We are proud to announce that on 10 November 2023, Laura Rijns successfully defended her PhD thesis cum laude! Her thesis is titled “Design rules to dynamically control supramolecular hydrogel-cell interactions”, and features innovative contributions to the field such as those described in her paper: “The Importance of Effective Ligand Concentration to Direct Epithelial Cell […]